The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

[1]  R. Kessler,et al.  Concordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD‐11 and other classification systems: analysis of data from the WHO's World Mental Health Surveys , 2018, Addiction.

[2]  Dan J Stein,et al.  Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, Lancet.

[3]  J. Leung,et al.  Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review , 2017, The Lancet. Global health.

[4]  R. Kessler,et al.  Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys , 2017, World psychiatry : official journal of the World Psychiatric Association.

[5]  Eyal Oren,et al.  Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 , 2017, Lancet.

[6]  Eyal Oren,et al.  Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[7]  Dan J Stein,et al.  Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[8]  Eyal Oren,et al.  Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[9]  Mohammad Hossein Khosravi,et al.  Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[10]  L. Barajas-Nava.  Oral Substitution Treatment of Injecting Opioid Users for Prevention of HIV Infection , 2017, The Journal of the Association of Nurses in AIDS Care : JANAC.

[11]  N. Campbell,et al.  Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation. , 2017, Drug and alcohol dependence.

[12]  T. Vos,et al.  Global, regional, and national incidence and prevalence, and years lived with disability for 328 diseases and injuries in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017 .

[13]  S. Popova,et al.  The relationship between different dimensions of alcohol use and the burden of disease—an update , 2017, Addiction.

[14]  L. Degenhardt,et al.  A systematic review of injecting-related injury and disease among people who inject drugs. , 2017, Drug and alcohol dependence.

[15]  T. Vos,et al.  Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement , 2016, PLoS medicine.

[16]  T. Vos,et al.  Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. , 2016, The Lancet. Infectious diseases.

[17]  L. Amato,et al.  Psychosocial interventions for psychostimulant misuse. , 2016, The Cochrane database of systematic reviews.

[18]  J. Rehm,et al.  Evidence of reducing ethanol content in beverages to reduce harmful use of alcohol. , 2016, The lancet. Gastroenterology & hepatology.

[19]  M. Petticrew,et al.  What the InBev merger means for health in Africa , 2016, BMJ Global Health.

[20]  S. Pearson,et al.  National trends in alcohol pharmacotherapy: Findings from an Australian claims database. , 2016, Drug and alcohol dependence.

[21]  R. Bruno,et al.  Concordance of ICD-11 and DSM-5 definitions of alcohol and cannabis use disorders: a population survey. , 2016, The lancet. Psychiatry.

[22]  Daniel C. Casey,et al.  Alcohol‐attributed disease burden in four Nordic countries: a comparison using the Global Burden of Disease, Injuries and Risk Factors 2013 study , 2016, Addiction.

[23]  J. Copeland,et al.  Psychosocial interventions for cannabis use disorder. , 2016, The Cochrane database of systematic reviews.

[24]  S. Popova,et al.  Comorbidity of fetal alcohol spectrum disorder: a systematic review and meta-analysis , 2016, The Lancet.

[25]  W. Hall,et al.  The health and social effects of nonmedical cannabis use. , 2016 .

[26]  Mirjam Kretzschmar,et al.  Disability weights for the Global Burden of Disease 2013 study. , 2015, The Lancet. Global health.

[27]  M. Forsman,et al.  Comparison of DSM-5 Classifications of Alcohol Use Disorders With Those of DSM-IV, DSM-III-R, and ICD-10 in a General Population Sample in Sweden. , 2015, Journal of studies on alcohol and drugs.

[28]  G. Dore,et al.  The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention , 2015, Current opinion in HIV and AIDS.

[29]  B. Grant,et al.  The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings , 2015, Social Psychiatry and Psychiatric Epidemiology.

[30]  B. Grant,et al.  Nosologic Comparisons of DSM-IV and DSM-5 Alcohol and Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. , 2015, Journal of studies on alcohol and drugs.

[31]  T. Vos,et al.  Assessing disability weights based on the responses of 30,660 people from four European countries , 2015, Population Health Metrics.

[32]  T. Babor,et al.  The concentration of the global alcohol industry and its penetration in the African region. , 2015, Addiction.

[33]  Janet B W Williams.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[34]  J. Rehm,et al.  Global alcohol exposure estimates by country, territory and region for 2005--a contribution to the Comparative Risk Assessment for the 2010 Global Burden of Disease Study. , 2013, Addiction.

[35]  J. Rehm,et al.  Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union , 2013, European Neuropsychopharmacology.

[36]  Alan D. Lopez,et al.  Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[37]  P. Vickerman,et al.  Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.

[38]  Wayne Hall,et al.  Extent of illicit drug use and dependence, and their contribution to the global burden of disease , 2012, The Lancet.

[39]  J. Parry,et al.  The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. , 2011, Addiction.

[40]  L. Degenhardt,et al.  What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. , 2011, Drug and alcohol dependence.

[41]  L. Degenhardt,et al.  Opioid dependence latent structure: two classes with differing severity? , 2011, Addiction.

[42]  Lawrence D Phillips,et al.  Drug harms in the UK: a multicriteria decision analysis , 2010, The Lancet.

[43]  T. Rhodes,et al.  Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed , 2010, The Lancet.

[44]  S. Popova,et al.  The relation between different dimensions of alcohol consumption and burden of disease: an overview. , 2010, Addiction.

[45]  A. Brennan,et al.  Estimated effect of alcohol pricing policies on health and health economic outcomes in England: an epidemiological model , 2010, The Lancet.

[46]  B. Grant,et al.  Statistical modeling of volume of alcohol exposure for epidemiological studies of population health: the US example , 2010, Population health metrics.

[47]  D. Segal.  Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) , 2010 .

[48]  Øystein Bakke,et al.  Vested Interests in Addiction Research and Policy Alcohol policies out of context: drinks industry supplanting government role in alcohol policies in sub-Saharan Africa , 2010, Addiction.

[49]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[50]  R P Mattick,et al.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. , 2009, The Cochrane database of systematic reviews.

[51]  D. Chisholm,et al.  Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol , 2009, The Lancet.

[52]  R. Mcketin,et al.  Major physical and psychological harms of methamphetamine use. , 2008, Drug and alcohol review.

[53]  C. Record.  A framework convention on alcohol control , 2007, The Lancet.

[54]  T. Lancet.  A Framework Convention on Alcohol Control , 2007, The Lancet.

[55]  Josep Maria Haro,et al.  Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative. , 2007, World psychiatry : official journal of the World Psychiatric Association.

[56]  I. Levav,et al.  Treatment gap in mental health care. , 2004, The Israel journal of psychiatry and related sciences.

[57]  Alan D. Lopez,et al.  Comparative quantification of health risks: Conceptual framework and methodological issues , 2003, Population health metrics.

[58]  C. Murray,et al.  On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. , 1999, Epidemiology.

[59]  Dean T. Jamison,et al.  World development report 1993 : investing in health , 1993 .

[60]  C. Beyrer,et al.  What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries. , 2014, The International journal on drug policy.

[61]  L. Degenhardt,et al.  Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. , 2011, Addiction.

[62]  R. Mattick,et al.  Predictors of social anxiety in an opioid dependent sample and a control sample. , 2010, Journal of anxiety disorders.

[63]  R. Mattick,et al.  Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. , 2008, The Cochrane database of systematic reviews.

[64]  BOMBAY CALCUrIA,et al.  World development report 1993--investing in health. , 1993, Communicable disease report. CDR weekly.